Therapeutic siRNA: State-of-the-Art and Future Perspectives Maik FriedrichAchim Aigner Review Article Open access 23 August 2022 Pages: 549 - 571
Plant-Derived Human Vaccines: Recent Developments Jennifer StanderSandiswa MbewanaAnn E. Meyers Review Article 12 July 2022 Pages: 573 - 589
Targeting Amyloid Fibrils by Passive Immunotherapy in Systemic Amyloidosis Mario NuvoloneAlice NevoneGiampaolo Merlini Review Article Open access 12 September 2022 Pages: 591 - 608
PROTACs: Current Trends in Protein Degradation by Proteolysis-Targeting Chimeras Jyotsana MadanVijay Kamal AhujaSanjeev Giri Review Article 13 September 2022 Pages: 609 - 623
Switching from One Biosimilar to Another Biosimilar of the Same Reference Biologic: A Systematic Review of Studies Hillel P. CohenSohaib HachaichiAndrew Blauvelt Systematic Review Open access 26 July 2022 Pages: 625 - 637
The Nocebo Effect in a Non-Medical Switching Program from Originator to Biosimilar Infliximab in Inflammatory Bowel Disease Krishneel DuttAshish SrinivasanDaniel Van Langenberg Original Research Article 12 August 2022 Pages: 639 - 644
Understanding US Physician and Pharmacist Attitudes Toward Biosimilar Products: A Qualitative Study Douglas J. RupertAlyssa M. JordanR. Craig Lefebvre Original Research Article 13 August 2022 Pages: 645 - 655
Real-World Effects of Biologics on Renal Function in Psoriatic Patients: A Retrospective Study Chun-Bing ChenYu-Tung HuangChing-Chi Chi Original Research Article 22 August 2022 Pages: 657 - 666
Teserpaturev/G47Δ: First Approval James E. Frampton AdisInsight Report 13 September 2022 Pages: 667 - 672
